SEARCH

SEARCH BY CITATION

  • 1
    Bridges SL Jr, Hughes LB, Mikuls TR, Howard G, Tiwari HK, Alarcon GS, et al. Early rheumatoid arthritis in African-Americans: the CLEAR Registry. Clin Exp Rheumatol 2003; 21(5 Suppl 31 ): S13845.
  • 2
    Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 31524.
  • 3
    Kamen DL, Barron M, Hollis BW, Oates JC, Bouali H, Bruner GR, et al. Correlation of vitamin D deficiency with lupus disease measures among Sea Island Gullah African Americans [abstract]. Arthritis Rheum 2005; 52 Suppl 9: S180.
  • 4
    Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 12717.
  • 5
    Nell VP, Machold KP, Stamm TA, Eberl G, Heinzl H, Uffmann M, et al. Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis. Ann Rheum Dis 2005; 64: 17316.
  • 6
    Kuhn KA, Kulik L, Tomooka B, Braschler KJ, Arend WP, Robinson WH, et al. Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis. J Clin Invest 2006; 116: 96173.
  • 7
    Schellekens GA, Visser H, de Jong BA, van den Hougen FH, Hazes JM, Breedveld FC, et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing cyclic citrullinated peptide. Arthritis Rheum 2000; 43: 15563.
  • 8
    Bas S, Genevay S, Meyer O, Gabay C. Anti-cyclic citrullinated peptide antibodies, IgM and IgA rheumatoid factors in the diagnosis and prognosis of rheumatoid arthritis. Rheumatology (Oxford) 2003; 42: 67780.